Novo Nordisk A/S
Stock futures are slightly lower after regional bank worries fuel market sell-off: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 16, 2025. Jeenah Moon | Reuters U.S. stock futures were slightly lower on Thursday night after the previous session saw a sell-off fueled by concerns about regional banks’ loan practices. Futures tied to the Dow Jones Industrial […]
Read More
Stocks making the biggest moves after hours: Novo Nordisk, Interactive Brokers, CSX and more
Check out the companies making headlines in after-hours trading. CSX Corporation — Shares of the railroad jumped 2% on the back of its strong quarterly results. CSX reported adjusted earnings of 44 cents per share on revenue of $3.59 billion for its third quarter, just beating analysts’ earnings expectations of 42 cents per share on […]
Read More
Stocks making the biggest moves midday: Oracle, Ferrari, Delta, Albemarle and more
Check out the companies making the biggest moves in midday trading: Oracle — Shares of the software company rose more than 3% on Thursday after Baird initiated coverage with a outperform rating and a $365 price taget. The firm said Oracle has a strong position in the artificial intelligence growth story. The stock has had […]
Read More
Novo Nordisk shares slip after pharma giant announces $4.7 billion U.S. acquisition
LONDON — Shares of Danish pharmaceutical giant Novo Nordisk fell 1.1% on Thursday after the company announced plans to acquire U.S. biotech firm Akero Therapeutics. The deal will see Novo pay $54 per share, valuing Akero at $4.7 billion, with the acquisition also including a contingent value right of $6 per share, potentially adding another […]
Read More
Stocks making the biggest moves premarket: Ferrari, PepsiCo, Delta, Akero Therapeutics and more
Check out the companies making the biggest moves in premarket trading: Ferrari — The luxury carmaker tumbled nearly 14% after it trimmed its electrification targets . Ferrari said it expects its 2030 sports car model line-up to be made up of 40% internal combustion engine cars, 40% hybrid and 20% fully electric vehicles. That’s down […]
Read More
Novo Nordisk to buy Akero for up to $5.2 billion for promising liver drug
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters Novo Nordisk said on Thursday it would buy Akero Therapeutics for up to $5.2 billion to add its promising experimental liver disease drug, in the first major deal […]
Read More
Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients […]
Read More
Quantum stocks Rigetti Computing and D-Wave surged double-digits this week. Here’s what’s driving the big move
Inside Google’s quantum computing lab in Santa Barbara, California. CNBC Quantum computing stocks are wrapping up a big week of double-digit gains. Shares of Rigetti Computing, D-Wave Quantum and Quantum Computing have surged more than 20%. Rigetti and D-Wave Quantum have more than doubled and tripled, respectively, since the start of the year. Arqit Quantum […]
Read More
Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]
Read More
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer‘s newest bet on obesity is already showing promise. The company last week said it would buy […]
Read More